Dr. Kaushik, as assistant professor of chemistry at the Department of Environmental Engineering of Florida Polytechnic University, is exploring advanced functional chemistries, nano-biotechnology, electrochemical biosensors, nanomedicine, and biomedical engineering for intelligent health wellness.
He is the recipient of various reputed awards for his significant contribution in the research field of nano-biotechnology for health care. Dr. Kaushik is scholarly accomplished as reflected by edited books, international peer-reviewed publications, and patents in nanomedicine and smart biosensors for personalized health care. For more than 10 years, Dr. Kaushik is an active mentor, supervisor, and helping various federal and private organizations as a fellow, consultant, and review board member.
During his research, Dr. Kaushik is actively involved in exploring tunable high-performance performance sensing systems for point-of-care application and nanomedicine for personalized therapy. To achieve his goal of intelligent personalized health wellness, Dr. Kaushik works in collaboration and seeks more globally.
Dr. Ronjon Nag is an inventor and entrepreneur. He is a founder and advisor/board member of multiple start-ups. His companies have been sold to Apple, BlackBerry, and Motorola. He has been awarded the Mountbatten Medal in the Royal Institution by the Institution of Engineering and Technology and has been the winner (Bounce Imaging-Board) of the $1m Verizon Powerful Answers Award. He has been a pioneer of smartphones and the 'app stores' they depend on.
He has worked on neural networks, touch screens, mobile search, voice recognition, text prediction, and handwriting recognition. He has a Ph.D. from Cambridge, an M.S from M.I.T, and a B.Sc. from Birmingham in the UK. Additionally, he is a Stanford Distinguished Careers Institute Interdisciplinary Fellow based at the Stanford Center for Language and Information (CSLI).
Professor de Magalhaes graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his Ph.D. in 2004 from the University of Namur in Belgium. Following a postdoc with genomics pioneer Prof George Church at Harvard Medical School, in 2008 Prof de Magalhaes was recruited to the University of Liverpool. He now leads the Integrative Genomics of Ageing Group which focuses on understanding the genetic, cellular, and molecular mechanisms of aging. Professor de Magalhaes has authored over 100 publications and given over 100 invited talks, including three TEDx talks. He is also Chief Scientific Officer of Swiss-based biotech Centaura. His ultimate goal is to develop interventions that preserve health and fend off age-related diseases by manipulating the aging process.
He is the founder and currently the president of the Swiss Society for Aging Research (www.ssfar.ch). He has received multiple awards, including NYAS Future Entrepreneur recognized by the New York Academy of Sciences, and is named under the top 1000 Longevity Leaders worldwide and the top 15 Longevity Influencers in Switzerland.
Research interests: Our recent work has shown that many health- and longevity-promoting interventions re-activate the expression of extracellular matrix (ECM) genes during aging (Ewald et al., Nature 2015, PMID:25517099). This ECM enhancement is required and sufficient for extending the lifespan of C. elegans. Our research efforts are focusing on exploring the mechanism(s) of how prolonged ECM homeostasis promotes healthy aging.
Expertise: C. elegans ECM, aging, protein aggregation, neurodegeneration (Alzheimer's disease), Insulin/IGF-1 signaling, NADPH oxidases, ROS, oxidative stress, automated lifespan assessment, genetic and chemical high-throughput screening.
Lab website: http://ewaldlab.com
Ravi Bala is an AgeTech Evangelist and a startup mentor in AgeTech and Remote Monitoring. He is a Co-Founder and former Board Member at HealthSignals, LLC, a leader in technology solutions for better senior living. An innovator and an expert in mobile health and digital strategy, he has a successful track record of creating and managing teams of independent thinkers. He has a tenacious dedication to compassion and dignity in the workplace. He is a teacher, a mentor, and a coach at heart and works with many startup ventures as an advisor.
He is currently Chair of the Capital for Good and board member for Girls First Fund – a global effort to end child marriage and is on the Advisory Board of CyberSeniors and the SeniorTrade Blog. He is also a mentor with the Silver Moonshots accelerator and a member of the Drexel University AgeWell Collaboratory. He has taught courses in Digital Strategy in multiple MBA programs in Philadelphia. His latest passion is changing the model of eldercare with the aid of Conversational AI, Robotics and Passive Monitoring.
Ms. Maha Abuyabis has passionately spent 9 years supporting Saudi biotech entrepreneurs to create ventures. She worked in business development at Badir Biotechnology Incubator (Badirbio) is one of the initiatives of King Abdulaziz City of Science and technology. Badirbio is one of the 1st incubators supporting biotech business in the kingdom of Saudi Arabia & During this time she supported a wide variety of biotechnology companies such as digital healthcare, molecular biology, and some startups with patented innovations from the ideation stage till the growth stage such as the stability laboratory service, Noawin (patient taxi application) & VOXEL( medical 3d printing technology).
While she was working, she completed her Master's degree in business administration from Dublin City University in Riyadh and spent 8 years of her life in India to pursue her education from high school till she earned her Bachelor's degree in Biotechnology from Bangalore University. Throughout her career path and experience in the local biotech industry, Maha moved to the private sector and worked in business development from sales and relationship manager and assessing new business opportunities. Lastly, Maha worked as a business development manager at a Research product and development company(RPDC) one of the subsidiaries of TAQNIA specialized in technology commercialization focusing on the pharmaceutical industry and Artificial intelligence and work closely with academic and R&D institutions to commercialize the potential outputs of their research and provide technology assessments.
At Shift Bioscience, Daniel is making safer drugs for cellular rejuvenation in humans by applying machine-learning 'driver' clocks to cellular reprogramming. Daniel is also a founding fellow of the OnDeck Longevity Biotech fellowship.
At U. Cambridge, Daniel used a computationally guided screen to identify molecules that eliminate mitochondrial DNA mutations. Daniel later founded Shift Bioscience, quickly embracing aging clocks, and guided Brendan Swain (CSO) to develop an accurate single cell aging clock using gene expression data.
This clock enabled a CRISPR screen for ageing, and excitingly, many clock genes were known 'drivers' of ageing phenotypes. The driver-clock methodology was applied to cell-reprogramming to identify putative drug targets for safe cellular rejuvenation and Daniel is now racing to validate these targets.
Cumulative experience of 12 years in Healthcare & Life sciences
· Healthcare innovations: Biotech, Digital Health, MedTech, Wellness
· Portfolio management & strategy
· Building partnerships and strategic initiatives
· Business and domain consultancy
Karolina Mackiewicz (MA Political Sciences, MA Futures Studies) has over 12 years of professional experience in international research and innovation cooperation for health and wellbeing.
She worked for the WHO European Healthy Cities network, leading the WHO Collaborating Centre for Healthy Cities and Urban Health in the Baltic Sea Region, and the Development Manager at MyData Global – an international non-for-profit advocating for a human-centric approach to personal data. When it comes to digital health, as a head of innovation unit of European Connected Health Alliance, she is especially interested in how technology and data can support the sustainable health systems of tomorrow, health literacy and socio-economic determinants of health.
Karolina will support the hackathon teams with her experience and expertise on: health systems, human-centric design, user-requirements for digital technologies, ethical use of personal data for health and wellbeing, and morbidity and ageing.